76537-23-0 Usage
Uses
Used in Pharmaceutical Industry:
6-Chloro-imidazo[1,2-a]pyrazine is used as a building block for the synthesis of various biologically active molecules and pharmaceutical drugs. Its versatile reactivity and potential pharmacological properties make it a valuable component in the development of new therapeutic agents for the treatment of various diseases and conditions.
Used in Chemical Industry:
In the chemical industry, 6-Chloro-imidazo[1,2-a]pyrazine serves as an important intermediate for the production of a wide range of chemical compounds, including dyes, pigments, and other specialty chemicals.
Used in Research and Development:
6-Chloro-imidazo[1,2-a]pyrazine is extensively used in research and development, particularly in the fields of medicinal chemistry and drug discovery. Its unique structure and reactivity make it a promising candidate for the design and synthesis of novel drug molecules with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 76537-23-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,5,3 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 76537-23:
(7*7)+(6*6)+(5*5)+(4*3)+(3*7)+(2*2)+(1*3)=150
150 % 10 = 0
So 76537-23-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H4ClN3/c7-5-4-10-2-1-8-6(10)3-9-5/h1-4H
76537-23-0Relevant academic research and scientific papers
COMPOUNDS AND THEIR METHODS OF USE
-
Page/Page column 93; 94; 124, (2018/06/12)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
Azabicyclo derivatives, preparation methods thereof, and pharmaceutical applications thereof
-
Paragraph 0286; 0287, (2016/10/09)
The invention relates to azabicyclo derivatives, preparation methods thereof, and pharmaceutical applications thereof. Specifically, the invention discloses compounds represented by a formula (I), or pharmaceutically acceptable salts, stereoisomers, solvates or prodrugs thereof. The invention also provides preparation methods of the derivatives, and applications of the derivatives in EGFR inhibitors. The definitions of the groups in the formula are defined in the specifications.
